Patterns of Multimorbidity in the Aged Population. Results from the KORA-Age Study by Kirchberger, Inge et al.
Patterns of Multimorbidity in the Aged Population.
Results from the KORA-Age Study
Inge Kirchberger
1,2*, Christa Meisinger
1,2, Margit Heier
1,2, Anja-Kerstin Zimmermann
1, Barbara
Thorand
1, Christine S. Autenrieth
1, Annette Peters
1, Karl-Heinz Ladwig
1, Angela Do ¨ring
1,3
1Institute of Epidemiology II, Helmholtz Zentrum Mu ¨nchen, German Research Center for Environmental Health, Neuherberg, Germany, 2MONICA/KORA Myocardial
Infarction Registry, Central Hospital of Augsburg, Augsburg, Germany, 3Institute of Epidemiology I, Helmholtz Zentrum Mu ¨nchen, German Research Center for
Environmental Health, Neuherberg, Germany
Abstract
Multimorbidity is a common problem in aged populations with a wide range of individual and societal consequences. The
objective of the study was to explore patterns of comorbidity and multimorbidity in an elderly population using different
analytical approaches. Data were gathered from the population-based KORA-Age project, which included 4,127 persons
aged 65–94 years living in the city of Augsburg and its two surrounding counties in Southern Germany. Information on the
presence of 13 chronic conditions was collected in a standardized telephone interview and a self-administered
questionnaire. Patterns of comorbidity and multimorbidity were analyzed using prevalence figures, logistic regression
models and exploratory tetrachoric factor analysis. The prevalence of multimorbidity ($2 diseases) was 58.6% in the total
sample. Hypertension and diabetes (Odds Ratio [OR] 2.95, 99.58% confidence interval [CI] [2.19–3.96]), as well as
hypertension and stroke (OR 2.00, 99.58% CI [1.26–3.16]) most often occurred in combination. This association was
independent of age, sex and the presence of other conditions. Using factor analysis, we identified four patterns of
multimorbidity: the first pattern includes cardiovascular and metabolic diseases, the second includes joint, liver, lung and
eye diseases, the third covers mental and neurologic diseases and the fourth pattern includes gastrointestinal diseases and
cancer. 44% of the persons were assigned to at least one of the four multimorbidity patterns; 14% could be assigned to
both the cardiovascular/metabolic and the joint/liver/lung/eye pattern. Further common pairs were the mental/neurologic
pattern combined with the cardiovascular/metabolic pattern (7.2%) or the joint/liver/lung/eye pattern (5.3%), respectively.
Our results confirmed the existence of co-occurrence of certain diseases in elderly persons, which is not caused by chance.
Some of the identified patterns of multimorbidity and their overlap may indicate common underlying pathological
mechanisms.
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Introduction
Multimorbidity is commonly defined as coexistence of two or
more chronic diseases in the same individual [1]. It is associated
with reduced health outcomes including functioning and quality of
life [2,3], more complex clinical management [4], specific health
care needs [5,6] and increased health care costs [7].
Since chronic diseases are associated with advanced age and the
number of aged persons in the population is rising, multimorbidity
increasingly becomes an important issue in health care. Studies
indicate that older people are more prone to develop two or more
chronic conditions than younger ones [8,9]. Thus, many studies
have been limited in focus to older persons when studying
multimorbidity. Reported prevalence rates of multimorbidity in
aged populations vary considerably depending on data sources,
considered diagnoses and study populations [10]. In Germany, the
prevalence of multimorbidity ranged from 67.3% in the 50–75
year old population studied by Nagel et al. [11] to 73% in the
study of Van den Bussche et al. [12] who analyzed claims data of
123,224 insured policy holders aged 65 and older. A recent
systematic review of 41 published studies worldwide reported a
range of multimorbidity between 55 and 98% of persons aged 65
and older [13].
Diseases that are common in older people may occur together
by chance. However, often ‘‘common pathways’’ may lead to
clustering of major chronic conditions. The impact of co-
occurrence on functional status is sometimes greater than the
sum of the impacts of the individual diseases [14]. Thus, analysis
and exploration of ‘‘common pathways’’ of these co-occurring
conditions offers the potential for improved medical management
and for targeted interventions.
However, only few studies have explored the natural clustering
of chronic conditions in aged populations so far. Some studies
identified the most common comorbid pairs [14–16] or analyzed
triadic combinations of diseases [12]. Only a few studies used
cluster analysis in order to obtain a general picture of the broad
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[16–18]. Scha ¨fer et al. [19] were the first who applied factor
analysis as a method to explore multimorbidity patterns and
identified three patterns: cardiovascular/metabolic disorders,
anxiety/depression/somatoform disorders and pain, and neuro-
psychiatric disorders.
The objective of the present study was to explore patterns of
comorbidity and multimorbidity in a Southern German popula-
tion aged 65–94 years.
Methods
Ethics statement
The KORA-Age study was approved by the Ethics Committee
of the Bavarian Medical Association. Written informed consent
has been obtained from the participants and all investigations have
been conducted according to the principles expressed in the
Declaration of Helsinki.
Study population
Data from the present study derived from the ‘‘KORA-Age’’
study which is a follow-up of all individuals aged 65–94 who have
participated in at least one of the four cross-sectional MONICA/
KORA surveys. These surveys have been conducted between
1984 and 2001 and included a random sample of the population of
the city of Augsburg and its two surrounding counties in Southern
Germany [20]. Details about study design, sampling method and
data collection are reported elsewhere [21]. In total, 17,607
persons participated in at least one of the four surveys. The
KORA-Age study population is restricted to the subgroup of 9,197
subjects who were born in 1943 or earlier. 2,734 of these 9,197
individuals died, 45 moved abroad or to an unknown location, and
427 refused to be contacted for any follow-up. A brief self-
administered questionnaire was mailed to the entire KORA
sample including the remaining 5,991 eligible persons of the
KORA-Age subgroup with known address between November
2008 and September 2009. All persons who did not answer within
4 weeks were sent a postcard reminder. Four weeks later, non-
responders were contacted by telephone and if the persons agreed
to participate, the questionnaire was administered via telephone.
In total, questionnaire data could be collected for 4,565 persons
(response 76.2%), of whom 3,833 returned the questionnaire by
mail and 732 (16.0%) were interviewed via telephone.
In addition to the data collected by questionnaire, in order to
collect more specific data relevant for elderly people, an extended
telephone interview was conducted with the 5,986 eligible persons
with known address between December 2008 and November
2009. Of these, 1,859 persons could not be contacted or refused to
participate. For 4,127 eligible persons, a telephone interview could
be performed either with the persons themselves (n=3,942) or
with a proxy (i.e. a family member or care giver) (n=185).
Data collection
The presence of chronic health conditions was self-reported by
the participants in the self-administered questionnaire and the
standardized telephone interview. In the questionnaire the
participants were asked whether they were ever diagnosed with
a myocardial infarction, hypertension, stroke, diabetes mellitus or
a malignant disease. In addition, participants should indicate
whether they had a coronary artery bypass graft surgery or
received a coronary artery stent.
The telephone interview was based on the self-report-generated
Charlson Comorbidity Index [22] (see Table 1). The participants
were requested to indicate whether they currently have asthma,
Table 1. Assessment of diseases in the KORA-Age Study.
Self-report generated Charlson Comorbidity Index KORA-Age Study
Disease Disease Source
Asthma, emphysema, or chronic bronchitis 3 Telephone interview
Arthritis or rheumatism 3 Telephone interview
Cancer, diagnosed in the past 3 years 3 Questionnaire
Diabetes 3 Questionnaire
Digestive problems (such as ulcer, colitis,
or gallbladder disease)
3 Telephone interview
Heart trouble (such as angina, congestive
heart failure, or coronary artery disease)
3 Questionnaire, telephone interview
Kidney disease 3 Telephone interview
Liver problems (such as cirrhosis) 3 Telephone interview
Stroke 3 Questionnaire
HIV illness or AIDS - Not requested*
Neurologic diseases such as multiple
sclerosis, Parkinson’s disease, or epilepsy
Telephone interview
Eye diseases such as glaucoma, cataract, macular degeneration,
diabetic retnopathy, or retinitis pigmentosa
Telephone interview
Hypertension Questionnaire
Depression Geriatric Depression scale (GDS-15)
administered via telephone interview
Anxiety Generalized Anxiety Disorder Scale-7 (GAD)
administered via telephone interview
*none of the participants reported antiretroviral therapy in the medication history.
doi:10.1371/journal.pone.0030556.t001
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inflammatory joint disease (e.g. arthritis) or a rheumatic disease,
a gastrointestinal disease (e.g. gastric or duodenal ulcer, colitis,
cholecystitis), heart complaints (e.g. angina pectoris, heart failure,
coronary heart disease), a kidney disease, or a liver disease (e.g.
cirrhosis). In addition to the disorders covered by the Charlson
Comorbidity Index, we asked for the presence of neurologic
diseases such as multiple sclerosis, Parkinson’s disease, or epilepsy,
whether the participant has or had a glaucoma or cataract, and
finally we requested the presence of any other disease which has
not been mentioned before. Depression was assessed using the
Geriatric Depression Scale (GDS-15) [23]. Scores above 10 points
were considered framing depression. The presence of an anxiety
disorder was assessed using the Generalized Anxiety Disorder
Scale-7 (GAD) [24]. Scores $10 points indicated the presence of
an anxiety disorder. An eye disease was deemed to be present if
participants indicated to have glaucoma or cataract or other eye
diseases such as macular degeneration, diabetic retinopathy, and
retinitis pigmentosa. Each single response to the open question on
other diseases was checked. If they contained information
regarding the above mentioned conditions, the presence of the
condition was modified accordingly. According to the available
information on diseases, 13 conditions were defined (Table 2).
Multimorbidity was defined as the co-occurrence of two or more
of these conditions within one person.
Data analysis
Age-standardized prevalences were calculated for each disease
and the presence of multimorbidity using the age distribution of
the German population on December 31, 2007. Occurrence of
multimorbidity was estimated by logistic regression modelling
adjusting for age and sex. The frequency of disease pairs was
computed. For the disease pairs with a frequency .5%, the
expected prevalence (prevalence disease A)6(prevalence disease B)
was computed and compared with the observed prevalence. In
order to determine the strength of the association between each
pair of co-occuring diseases and to control for possible confound-
ers, logistic regression with adjustment for age, sex, and all other
diseases was performed. The level of significance was set to
p,0.0042 applying Bonferroni correction for multiple testing.
Patterns of multimorbidity were analyzed by exploratory factor
analysis. We applied the principal factor method and used a
tetrachoric correlation matrix, which takes into account the
dichotomy of the data [25]. The Kaiser-Meyer-Olkin measure was
calculated to estimate the sampling adequacy for performing a
factor analysis, and cumulative percent described the proportion of
variance of the morbidity data that can be explained by the
patterns. Factors with an eigenvalue of at least 1.0 were considered
as substantial. We assumed that there will be associations among
the factors, thus we used an oblique (oblimin) rotation of factor
loading matrices.
We examined the frequencies of multimorbidity patterns by
assigning individuals to a pattern if they experienced at least two
diseases with a factor loading of $0.25 on the corresponding
pattern. Age and sex-related differences in the pattern prevalence
were analyzed using logistic regression modelling.
Results
Of the 4127 subjects, 51.2% were female. 66.2% were married
or lived with a partner. The mean age was 73.466.1 years.
Women were significantly less likely to be married or to live with
a partner than men (52.2% vs. 80.8%). Hypertension, eye
diseases, and heart diseases were the most common disorders,
with prevalences of 57.9%, 38.1%, and 25.8%, respectively
(Table 2). The number of disorders ranged from 0 to 10
(Table 3). The median number of conditions was 2 (25
th
percentile: 1; 75
th percentile: 3). Women did not differ
significantly from men, whereas a higher number of conditions
was related to older age.
The prevalence of multimorbidity was 58.6% (95% confidence
interval: 57.0–60.2) in the total sample. Logistic regression analysis
revealed a significant interaction effect of age and sex regarding
the occurrence of multimorbidity (p=0.02). While multimorbidity
was significantly associated with increasing age, only in the age
group $85 years women were significantly more likely than men
to have $2 conditions.
Table 4 shows the 12 most common pairs of conditions, their
observed and expected frequency and the odds ratios testing their
association. Hypertension, eye diseases, diabetes mellitus, and
heart diseases were most often associated with a second condition.
The occurrence of hypertension in combination with heart disease,
diabetes, or stroke, respectively was more likely than expected, as
well as the occurrence of eye diseases in combination with
diabetes, joint diseases or lung diseases. Heart diseases also
occurred more often than expected in combination with diabetes
or joint diseases. These results were confirmed after adjustments
for age, sex, and all other diseases (Table 4). Hypertension and
diabetes, as well as hypertension and stroke emerged as the most
strongly associated pairs of diseases.
In the factor analysis, four factors emerged with a total of 47.8
cumulative percent. The Kaiser-Meyer-Olkin measure of 0.72
indicated a moderate sampling adequacy. The first pattern
(eigenvalue 1.90) was characterized by high loadings for
hypertension, heart diseases, diabetes and stroke and could be
named as cardiovascular/metabolic disorders. The second factor
(eigenvalue 1.76) was characterized by moderate factor loadings of
joint, liver, lung and eye diseases. The third factor (eigenvalue
1.61) could be characterized by high factor loadings of mental
diseases and neurologic diseases, and consequently was interpreted
as multimorbidity pattern of mental and neurologic disorders. The
fourth pattern (eigenvalue 1.54) showed high factor loadings of
gastrointestinal diseases and cancer. While some diseases including
hypertension, mental disorders and cancer were clearly associated
Table 2. Prevalences of the 13 chronic conditions.
Condition Prevalence [%] 95% confidence interval
Hypertension 57.9 [56.3–59.4]
Eye disease 38.1 [36.6–39.6]
Heart disease 25.8 [24.4–27.1]
Diabetes mellitus 16.8 [15.6–17.9]
Joint disease 16.2 [15.1–17.4]
Lung disease 10.3 [9.4–11.2]
Gastrointestinal disease 8.7 [7.8–9.6]
Mental disease 8.4 [7.5–9.3]
Stroke 7.0 [6.2–7.8]
Cancer 4.3 [3.6–4.9]
Kidney disease 4.0 [3.4–4.6]
Neurological disease 3.4 [2.9–4.0]
Liver disease 2.4 [1.9–2.9]
doi:10.1371/journal.pone.0030556.t002
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loadings .0.25 on at least two factors.
Table 5 depicts the frequencies of the four patterns. The
cardiovascular/metabolic diseases pattern was the most common
one, followed by the joint/liver/lung and eye diseases pattern. The
association of the occurrence of the single patterns with age and
sex was analyzed using logistic regression modelling. Higher age
was significantly related to a higher frequency of joint, liver, lung
and eye diseases after adjustments for sex and the interaction
between age and sex (p=.001; odds ratio (OR) 1.068, 95%
confidence interval [1.029–1.108]. Regarding the occurrence of
the cardiovascular/metabolic disease pattern, a significant inter-
action effect between age and sex (p=.006) was found with a
higher occurrence for males in the younger age groups and a lower
in the oldest age group. Regarding the two further patterns, no
significant age or sex differences were found.
Among the total sample, 56.0% could not be assigned to any of
the four disease patterns. 24.8% of the people could be assigned to
one disease pattern, 14.4% to two, 4.2% to three, and 0.7% to all
four patterns.
When analyzing pair-wise occurrence of disease pattern, 14% of
the people could be assigned to both the cardiovascular/metabolic
pattern and the joint/liver/lung/eye pattern. Further common
pairs are the mental/neurologic pattern combined with the
cardiovascular/metabolic pattern (7.2%) or the joint/liver/lung/
eye pattern (5.3%).
Discussion
In the present study we used different approaches to describe
comorbidity and multimorbidity in the elderly German popula-
tion. Hypertension and diabetes, as well as hypertension and
stroke were the two diseases which occurred most commonly in
combination. This association was independent of age, sex and the
presence of other conditions. Furthermore, we identified four
patterns of multimorbidity: the first pattern includes cardiovascu-
lar and metabolic diseases, the second includes joint, liver, lung
and eye diseases, the third covers mental and neurologic diseases
and the fourth pattern includes gastrointestinal diseases and
cancer.
Table 3. Number of conditions stratified by age group and sex.
No. of conditions
Total sample
(n=4067)
,75 years
(n=2541)
75–84 years
(n=1315)
$85 years
(n=211)
Men (n=1225) Women (n=1316) Men (n=664) Women (n=651) Men (n=93) Women (n=118)
0 507 (12.5%) 211 (17.2%) 197 (15.0%) 57 (8.6%) 33 (5.1%) 3 (3.2%) 6 (5.1%)
1 1096 (27.0%) 370 (30.2%) 416 (31.6%) 142 (21.4%) 141 (21.7%) 19 (20.4%) 8 (6.8%)
2 1093 (26.9%) 335 (27.3%) 357 (27.1%) 161 (24.3%) 186 (28.6%) 21 (22.6%) 33 (28.0%)
3 713 (17.5%) 187 (15.3%) 193 (14.7%) 149 (22.4%) 129 (19.7%) 20 (21.5%) 35 (29.6%)
4–6 621 (15.3%) 116 (9.5%) 142 (10.8%) 147 (22.1%) 156 (24.0%) 28 (30.1%) 32 (27.1%)
.6 37 (0.8%) 6 (0.5%) 11 (0.8%) 8 (1.2%) 6 (0.9%) 2 (2.2%) 4 (3.4%)
$2 2464 (60.6%) 581 (47.4%) 613 (46.6%) 465 (70.0%) 477 (73.3%) 71 (76.3%) 104 (88.1%)
doi:10.1371/journal.pone.0030556.t003
Table 4. Most frequently co-occuring pairs of conditions and their observed and expected prevalences.
Observed Expected Ratio observed/expected
Crude OR
[99.58% CI] p-value
Adjusted OR
[99.58% CI]* p-value
#
Hypertension and eye diseases 23.80 22.64 1.05 1.21 [1.01–1.46] 0.003 1.04 [0.84–1.28] 0.632
Hypertension and heart diseases 18.39 15.58 1.18 1.86 [1.50–2.30] ,.001 1.67 [1.32–2.11] ,.001
Hypertension and diabetes 13.68 10.11 1.35 3.20 [2.41–4.25] ,.001 2.95 [2.19–3.96] ,.001
Hypertension and joint diseases 10.08 9.70 1.04 1.13 [0.88–1.44] 0.160 1.00 [0.77–1.30] 0.992
Eye diseases and diabetes 8.11 6.62 1.22 1.53 [1.20–1.94] ,.001 1.36 [1.04–1.77] 0.001
Eye and joint diseases 7.57 6.35 1.19 1.45 [1.14–1.85] ,.001 1.25 [0.96–1.63] 0.018
Hypertension and lung diseases 6.78 6.23 1.09 1.28 [0.95–1.73] 0.020 1.13 [0.82–1.57] 0.268
Heart diseases and diabetes 6.39 4.56 1.40 1.84 [1.43–2.36] ,.001 1.46 [1.11–1.92] ,.001
Eye and lung diseases 5.43 4.08 1.33 1.81 [1.35–2.42] ,.001 1.65 [1.20–2.28] ,.001
Hypertension and stroke 5.32 4.12 1.29 2.39 [1.59–3.59] ,.001 2.00 [1.26–3.16] ,.001
Heart diseases and joint diseases 5.31 4.37 1.21 1.40 [1.08–1.82] 0.002 1.24 [0.93–1.64] 0.034
Hypertension and gastrointestinal
diseases
5.30 4.70 1.13 1.07 [0.77–1.47] 0.562 0.93 [0.66–1.31] 0.530
Results from logistic regression models testing the association between pairs of conditions.
*Odds ratios (OR) were adjusted for age, sex and all other diseases.
doi:10.1371/journal.pone.0030556.t004
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studies, because these remarkably differ regarding data sources,
populations, and number and type of diseases [10]. However, the
prevalence of multimorbidity of 58.6% in our study fits well with
the reported range of multimorbidity rates in elderly populations
[3,9,11,13,26]. While the relation of multimorbidity with age is
well documented [8,26,27], the reports on differences between the
sexes are conflicting. Some studies did not retrieve significant
differences between women and men regarding multimorbidity
[8,12,27] whereas others found women older than 65 [26] or 77
years [28] to be more likely to be multimorbid than men. In our
study, only women aged $85 years were more likely than men to
report two or more conditions.
The most common comorbid pairs found in our study were
hypertension and diabetes, hypertension and stroke, as well as
hypertension and heart disease which reflect well-established
pathophysiological associations [29–31]. Furthermore, the associ-
ation between heart disease and diabetes indicated the existence of
a cardiovascular/metabolic disorder pattern. Consistent with the
pair-wise associations between cardiovascular disorders and
diabetes, the factor analysis identified a pattern that covered these
conditions and had the highest frequency of 31.8% within the
study sample.
Regarding the pair-wise co-occurrence of diseases, we found a
significant association between eye diseases and diabetes. It may be
explained by the possible microvascular complications of diabetes
such as diabetic retinopathy [32], and the occurrence of cataract,
which was reported to be more common in persons with diabetes
thaninnon-diabeticpersons[33].Furthermore,rheumatoidarthritis
can have a number of extraarticular manifestations related to the
heart as well as to the eyes [34]. This fact might have contributed to
the significant relation between joint diseases and heart diseases, and
joint diseases and eye diseases, respectively, detected in our study.
Finally, eye and lung diseases co-occurred significantly more often
than expected. This finding contributes to the current controversial
discussion about a relation between the systemic inflammation and/
or decreased systemic oxygenation associated with lung diseases and
the risk of age-related macular degeneration [35,36]. An additional
potential explanation for this finding could be the reported increased
risk of cataracts associated with long-term use of corticosteroids in
the treatment of asthma [37].
In accordance with other studies which examined multi-
morbidity using cluster or factor analysis, we found a pattern of
cardiovascular and related diseases. In two other studies,
metabolic diseases [18] or stroke [17] were included in this
pattern. We can confirm the results of Scha ¨fer et al. [19] that both
conditions, diabetes and stroke, were assigned to the cardiovas-
cular/metabolic pattern.
Moreover, we found a disease pattern that covers mental
disorders (depression, anxiety) and neurologic disorders such as
Parkinson’s disease, multiple sclerosis or epilepsy. This finding is
overall consistent with Cornell et al. [18] who identified a mixed
anxiety-depression cluster in their sample. Neurologic disorders
like Parkinson’s disease, multiple sclerosis or epilepsy were not
considered in their study. Our results are consistent with the
growing literature on the comorbid relationship and biological
association between depression and anxiety [38,39] as well as on
the frequent association of depression and anxiety with other
neurologic diseases [40,41].
Of interest, we demonstrated in our study that the mental/
neurologic pattern frequently overlapped with the cardiovascular/
metabolic pattern or the joint/liver/lung/eye pattern. This finding
supports the current discussion about inflammatory as well as
oxidative and nitrosative stress pathways that underpin the
common pathophysiology of depression and disorders such as
cardiovascular disease, diabetes, stroke, chronic obstructive
pulmonary disease, rheumatoid arthritis, and inflammatory bowel
disease, and that activation of these pathways contributes to shared
risk [42,43].
Since the mental/neurologic pattern emerged as a relevant
factor of multimorbidity in our study, we agree with Maes et al.
[42] that mental conditions should be assessed in studies on
multimorbidity in the elderly population. It may also be useful to
include dementia, which was not done in our study. Unfortunate-
ly, neither mental nor neurological conditions are included in the
most frequently used comorbidity measure, the Charlson Comor-
bidity Index [22].
Our study is the second published study which applied factor
analysis methodology to explore the structure of multimorbidity in
elderly people. Recently, Scha ¨fer et al. [19] have demonstrated the
benefit of applying a factor analytical approach which allows
diseases to be associated with more than one pattern, in contrast to
cluster analysis. They have shown that seven out of 46 diseases
included in their analysis where associated with different patterns,
for instance depression, stroke and cardiac insufficiency. In our
study we could confirm that almost one half of the 13 diseases,
including stroke and heart diseases, correlated with more than one
pattern, whereas the mental diseases including depression were
clearly associated with only one factor. In accordance with Scha ¨fer
et al. [19], we detected a limited number of factors that could be
well interpreted. The model fit, however, was moderate with a rate
of cumulative percent of 48% and a Kaiser-Meyer-Olkin measure
of 0.72.
The number and selection of diseases considered in our study
and the self-report methodology used, surely will have affected our
results. Although our assessment of diseases was generally based on
the Charlson Comorbidity Index [22], we have added some
disorders which seemed highly relevant for exploring multi-
morbidity in the elderly population, such as hypertension, eye
diseases, mental diseases and neurological diseases. On the one
Table 5. Number and percent of persons who could be assigned to the multimorbidity patterns.
Total (n=2846) Men (n=1411)
Women
(n=1435) p-value
,75 years
(n=1439)
75–84 years
(n=1174)
$85 years
(n=233) p-value
Cardiovascular/metabolic disorders 1314 (31.8%) 699 (34.7%) 615 (29.1%) ,0.01 678 (47.1%) 539 (45.9%) 97 (41.6%) ,0.01
Liver/lung/joint/eye disorders 1041(25.2%) 479 (23.7%) 562 (26.7%) 0.04 490 (34.1%) 456 (38.8%) 95 (40.8%) ,0.01
Mental/neurologic disorders 398 (9.7%) 187 (9.3%) 211 (10.0%) 0.44 219 (15.2%) 150 (12.8%) 29 (12.4%) ,0.01
Gastrointestinal disorders and cancer 93 (2.3%) 46 (2.3%) 47 (2.2%) 0.90 52 (3.6%) 29 (2.5%) 12 (5.2%) 0.01
Results of Chi
2-test for sex and age-group differences.
doi:10.1371/journal.pone.0030556.t005
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bility with other studies. On the other hand, these additional
disorders emerged as the most important ones in the analysis and
thus contributed to the validity of the study. Furthermore, we used
standard multi-item scales for the assessment of depression and
anxiety as compared to simply ask patients for the presence of
these problems. This might also have influenced our results. In
addition, we have only assessed the occurrence of a disease without
taking into account the severity. Finally, our study had a cross-
sectional design and therefore allows no conclusions regarding
causal relationships among disease clusters.
Underlying these limitations is the lack of an internationally
accepted standard for assessing multimorbidity. A conceptual
framework including a consistent measurement approach of
multimorbidity for different study populations would strongly
facilitate comparisons between studies and populations [27].
The results of our study contribute to a deeper understanding of
the complexity of multimorbidity by characterizing the association
between diseases in multiple ways. Further research is needed to
determine the impact of different multimorbidity patterns on
various health outcomes including mortality, disability, quality of
life, and health care costs. Negative synergy effects of multiple
disease patterns in individual patients need further attention [3].
Specifically, the knowledge about the health care needs associated
with different multimorbidity patterns might help us to improve
the life of elderly persons with multiple diseases.
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